MACK Past Earnings image   This MACK past earnings page last updated 11/7/2022
MACK Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/3/2022-0.030
Q2 20228/4/2022-0.040
Q1 20225/5/2022-0.010
Q4 20213/9/2022-0.030
Q3 202111/4/2021-0.040
Q2 20218/5/2021-0.060
Q1 20215/6/2021-0.050
Q4 20203/10/2021-0.080
Q3 202011/4/2020-0.080
Q2 20208/7/2020-0.090
Q1 20205/7/20200.020
Q4 20193/12/2020-0.050
Q3 201911/12/2019-0.210
Q2 20197/17/2019-0.710
Q1 20195/10/2019-0.780
Q4 20183/6/2019-0.97
Q3 201811/7/2018-0.92
Q2 20188/7/2018-1.33
Q1 20185/8/2018-1.33
Q4 20173/12/2018-0.89
Q3 201711/8/2017-0.4
Q2 20178/9/2017-2.200
Q1 20175/10/2017-2.200
Q4 20163/1/2017-2.500
Q3 201611/9/2016-2.300
Q2 20168/4/2016-4.000
Q1 20165/2/2016-3.300
Q4 20152/25/2016-4.100
Q3 201511/9/2015-3.800
Q2 20158/10/2015-2.100
Q1 20155/7/2015-3.200
Q4 20142/26/2015-0.900
Q3 201411/10/2014-2.700
Q2 20148/11/2014-1.700
Q1 20145/1/2014-2.700
Q4 20132/27/2014-3.300
Q3 201311/7/2013-3.900
Q2 20138/8/2013-3.100
Q1 20135/13/2013-2.900
Q4 20123/14/2013-2.600
MACK Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/3/2022NA
Q2 20228/4/2022NA
Q1 20225/5/2022NA
Q4 20213/9/2022NA
Q3 202111/4/2021NA
Q2 20218/5/2021NA
Q1 20215/6/2021NA
Q4 20203/10/2021NA
Q3 202011/4/2020NA
Q2 20208/7/2020NA
Q1 20205/7/2020NA
Q4 20193/12/2020NA
Q3 201911/12/2019NA
Q2 20197/17/2019NA
Q1 20195/10/2019NA
Q4 20183/6/2019NA
Q3 201811/7/2018NA
Q2 20188/7/2018NA
Q1 20185/8/2018NA
Q4 20173/12/2018NA
Q3 201711/8/2017NA
Q2 20178/9/2017NA
Q1 20175/10/2017NA
Q4 20163/1/201761.24M
Q3 201611/9/201628.07M
Q2 20168/4/201633.68M
Q1 20165/2/201621.28M
Q4 20152/25/201621.42M
Q3 201511/9/201516.44M
Q2 20158/10/201536.56M
Q1 20155/7/201514.84M
Q4 20142/26/201533.91M
Q3 201411/10/201428.00M
Q2 20148/11/201427.80M
Q1 20145/1/201413.03M
Q4 20132/27/20147.82M
Q3 201311/7/20136.86M
Q2 20138/8/201318.50M
Q1 20135/13/201314.70M
Q4 20123/14/201314.20M
Quotes delayed 20 minutes

Email EnvelopeFree MACK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Merrimack Pharmaceuticals (MACK) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

MASI Past Earnings
MBIO Past Earnings
MBOT Past Earnings
MBRX Past Earnings
MCK Past Earnings
MCRB Past Earnings
MD Past Earnings
MDGL Past Earnings
MDT Past Earnings
MDXG Past Earnings

MACK Past Earnings Q&A

What was the best and worst MACK past earnings results?
For Merrimack Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest MACK past earnings result in our data set was 0.020/share posted in Q1 2020, while the lowest was in Q4 2015 when MACK posted -4.100/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2016 when MACK reported 61.24M in revenue, while the quarter with the lowest revenue in our data set was Q3 2022 at NA of revenue.

  Suggested answer: There are 40 MACK past earnings results in our data set.

On this page we presented the MACK past earnings date information for Merrimack Pharmaceuticals. Reviewing that MACK Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2020, when MACK posted gaap of 0.020/share. Meanwhile the lowest MACK past earnings result was in Q4 2015, when MACK posted gaap of -4.100/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2016 when MACK reported 61.24M in revenue, while the smallest revenue quarter was Q3 2022 when MACK reported NA in revenue.

Any self directed investor doing their due diligence on MACK or any other given stock can benefit from researching all of the Merrimack Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Merrimack Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for MACK. Thanks for visiting, and the next time you need to research MACK past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Funds Holding PHX, ATO Dividend History, UFAB Price Target.

 

MACK Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.